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Purpose: To describe the endovascular treatment of intra-abdominal perigraft seromas
associated with small-caliber expanded polytetrafluoroethylene (ePTFE) grafts.
Case Reports: Two patients who underwent hybrid repair of thoracoabdominal aortic
aneurysms in which renovisceral bypass grafts were implanted presented with large,
symptomatic perigraft seromas. The 5- to 8-mm-diameter ePTFE bypass grafts believed to
be involved in the seromas were successfully relined with self-expanding Viabahn stent-
grafts in percutaneous procedures. The patients’ symptoms were relieved, and imaging
follow-up (18 and 10 months, respectively) has shown near complete resorption of the
seromas.
Conclusion: It is expected that this minimally invasive technique could be very valuable in
treating aortic, renovisceral, and peripheral perigraft seroma.
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Perigraft seroma is a persistent, sometimes
expanding, fluid collection confined within a
fibrous pseudomembrane surrounding a vas-
cular prosthesis, typically those made of
expanded polytetrafluoroethylene (ePTFE)
material. This sequela has been regularly
reported since the early 1980s, but there is
no standardized treatment for this complica-
tion.1 We report two cases of symptomatic
perigraft seroma developing after renovisc-
eral bypass surgery that were successfully
treated by relining the grafts with self-expand-
ing stent-grafts.
CASE REPORTS
A 57-year-old patient with Crawford III thora-
coabdominal aortic aneurysm was treated in
May 2010 with a staged hybrid procedure. In
the first stage, renal and visceral arteries were
bypassed with ePTFE grafts. An 8-mm ePTFE
feeding graft was attached to the left external
iliac artery; its distal end was connected to the
superior mesenteric artery (SMA) using the
Viabahn Open Revascularization TEChnique
(VORTEC)2 with a 9-mm35-cm Viabahn stent-
graft (W.L. Gore & Associates, Flagstaff, AZ,
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USA). Further, 2 branches (6-mm ePTFE
grafts) were attached to the feeding graft for
the celiac trunk (anastomosis to the hepatic
artery) and left renal artery, in which VORTEC
was also used (7-mm35-cm Viabahn; Fig. 1A).
The thoracoabdominal aneurysm was exclud-
ed some weeks later in an endovascular repair
that required a periscope endograft to be
placed to the right renal artery (7-mm35-cm
Viabahn).3
During follow-up, the patient developed a
large perigraft seroma (70396362 mm) ac-
companied by abdominal discomfort, espe-
cially during the night (Fig. 1B). In September
2011, it was decided to treat the seroma using
a relining technique. Via a percutaneous
transfemoral access, a 9-mm35-cm Viabahn
stent-graft was deployed inside the 8-mm
SMA graft. Another 9-mm310-cm Viabahn
stent-graft was used in the 6-mm celiac trunk
graft (Fig. 1C). Finally, Viabahn stent-grafts
covered most of the endoluminal surface of
the ePTFE bypass grafts that were thought to
be responsible for the seroma, as both were
surrounded or adjacent to the seroma. The
procedure was uneventful, and after a follow-
up of 6 months, the seroma had decreased by
50%, and the patient was asymptomatic. After
18 months, the seroma has nearly disap-
peared (Fig. 1D). In addition, an endoleak type
Ib was treated during follow-up using parallel
grafts to the left lower renal artery and right
renal artery and an aortic stent-graft distal
extension.
The second patient was a 64-year-old
woman who was treated for a Crawford I
thoracoabdominal aneurysm with a staged
hybrid procedure in March 2008. In the first
stage, the renovisceral bypass grafts were
implanted. A 10-mm ePTFE feeding graft was
attached to the left external iliac artery
proximally, and its distal end was anasto-
mosed to an 8-mm ePTFE graft intended to
revascularize the celiac trunk (anastomosis on
the hepatic artery). Three 5-mm ePTFE branch
grafts were attached to the feeding graft using
VORTEC and a 6-mm35-cm Viabahn stent-
graft to the right renal artery, a 5-mm35-cm
Viabahn to the left renal artery, and a 7-
mm35-cm Viabahn to the SMA. The aneu-
rysm was excluded endovascularly a few
weeks later (Fig. 2A).
Figure 1^ (A) CT scan reconstruction showing the renovisceral bypasses. The asterisks denote the Viabahn
stent-grafts used as connectors to the superior mesenteric and the left renal arteries in the VORTEC
technique. (B) Perigraft seroma. (C) CT scan reconstruction showing relining (between arrows) of the grafts to
the SMA and the celiac trunk. (D) Appearance of the perigraft seroma 13 months after relining.
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As in the first case, a large symptomatic
perigraft seroma (1703113385 mm) devel-
oped around the renovisceral grafts in fol-
low-up (Fig. 2B). It was percutaneously
drained with a pigtail catheter, but this proved
ineffective in reducing the volume. The cap-
sule was resected in an open procedure, but
the seroma reappeared soon thereafter, ulti-
mately compressing the left renal artery
bypass, which thrombosed. A definitive relin-
ing of the visceral grafts responsible for the
seroma was performed, implanting a 7-
mm35-cm Viabahn in the proximal part of
the graft serving the SMA and two 9-mm35-
cm stent-grafts in the branch to the celiac
trunk (Fig. 2C). The patient became asymp-
tomatic rapidly, and the seroma decreased by
70% within 3 months (Fig. 2D). She is
currently symptom-free at 10 months after
the relining.
DISCUSSION
Perigraft seroma has been noted after most
types of peripheral vascular reconstructions,
but mostly in subcutaneously tunneled grafts
(axillofemoral bypass and dialysis access
grafts).1 It is uncertain whether seroma in-
volving Dacron and ePTFE grafts is caused by
the same mechanisms, but it is obviously
more frequent with the latter.4 The larger pore
size of ePTFE (~30 lm in size) compared to
Dacron may play a role in the pathogenesis of
perigraft seroma. Unknown patient or proce-
dure-specific factors may impact the porosity
of ePTFE grafts, leading to leakage (ultrafiltra-
tion) through the graft wall, eventually result-
ing in perigraft seroma. Other possible
mechanisms include the administration of
heparin, lipolysis, and damage of the graft
during placement, or a subclinical infection.5
The presence of a perigraft seroma makes
graft incorporation into surrounding tissue
impossible,1 so there is no tissue ingrowth
into the graft pores and porosity remains
high.6 The incidence of perigraft seroma is
probably underreported, but the complication
deserves attention due to the associated
morbidity, e.g., graft thrombosis from com-
pression,4 skin necrosis, secondary graft
infection, anastomotic aneurysm formation,
and anastomotic bleeding.7
Treatment of perigraft seroma might in-
clude incision and drainage or aspiration of
the fluid or observation.8 However, as we saw,
needle aspiration or drainage is often ineffec-
tive.6,9 Other options are external surface
sealing by application of fibrin glue compo-
nents,5 wrapping the graft with saphenous
vein,10 or sac imbrication with suture and
replacement of the graft.4,7,9 However replace-
ment of the graft with a new ePTFE graft
Figure 2 ^ (A) CT scan reconstruction showing renovisceral bypasses. The arrows point out the Viabahn
stent-grafts used as connectors for the superior mesenteric artery and both renal arteries. (B) Perigraft
seroma. (C) CT scan reconstruction showing relining (between arrows) of the grafts to the superior
mesenteric artery and the celiac trunk. (D) Appearance of the seroma 3 months after relining.
870 STENT-GRAFT RELINING FOR PERIGRAFT SEROMA J ENDOVASC THER
Lachat et al. 2013;20:868–871
results in a surprising high percentage of
recurrent seroma in most reports.11
The idea of relining surgical grafts with
stent-grafts is derived from a similar problem
that has been noted with early versions of the
ePTFE and even Dacron aortic stent-grafts.12
Some of these fabrics are highly porous and
have been suspected of causing endotension
and secondary aneurysm sac growth.4,12,13 In
such cases, relining most of the surface of the
aortic stent-graft was effective in stopping
aneurysm growth, and sac shrinkage was
often observed.13,14 The relining technique
has been applied to thoracic prosthetic grafts
as well,15 but not to our knowledge in small
bypass grafts. In our patients, we decided to
use this approach in the renovisceral bypass-
es. The significant regression we observed in
these seromas after relining the ePTFE bypass
grafts suggests that the method is viable in
smaller conduits. The question of how poros-
ity is altered in some patients remains
unanswered, however. Relining should not
be performed as a standalone measure in
infected grafts because infection has to be
addressed surgically.
Conclusion
These cases show that using self-expanding
stent-graft to reline ePTFE peripheral grafts,
such as those used in renovisceral bypass
surgery, is effective in the short term for
treating symptomatic perigraft seroma. Relin-
ing can be performed percutaneously under
local anesthesia and is applicable to most
aortic, renovisceral, and/or peripheral grafts.
More experience and long-term results are
mandatory before this method can be recom-
mended widely, especially to treat hemodial-
ysis grafts.
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